Market Tracker

10/23 3:42am ET

Actavis PLC (NYSE:ACT)

231.41
Data as of Oct 22
 -0.72 / -0.31%
Today’s Change
143.71
Today|||52-Week Range
249.94
+37.74%
Year-to-Date

Today’s Trading

Previous close232.13
Today’s open232.08
Day’s range230.46 - 235.83
Volume1,648,280
Average volume (3 months)2,430,256
Market cap$61.3B
Dividend yield--
Data as of 4:04pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)-793.42%
Earnings growth (this year)+39.96%
Earnings growth (next 5 years)+18.43%
Revenue growth (last year)+46.71%
P/E ratioNM
Price/Sales2.75
Price/Book4.24

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.80-1.89%
AGNAllergan Inc-3.35-1.80%
LLYEli Lilly and Co0.000.00%
CELGCelgene Corp-0.21-0.22%
Data as of 4:01pm ET, 10/22/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$3.10
Annual revenue (last year)$8.7B
Annual profit (last year)-$750.4M
Net profit margin-8.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts